Summary: Psychedelic Health covers the completion of enrollment for our confirmatory Phase 3 trial of MDMA-assisted therapy for PTSD. Per the special protocol agreement negotiated with the U.S. FDA, this …
Summary: *Content warning: Suicide* Smoky Mountain News explores MAPS’ expanded access program for MDMA-assisted therapy for treatment-resistant PTSD by interviewing Dr. Raymond Turpin of Pearl Psychedelic …
Summary: Natalie Lyla Ginsberg, M.S.W., of MAPS joins FOX 7 Austin to discuss the status of the wider field of psychedelic research and explain the results of MAPS’ first Phase 3 trial of MDMA-assisted …
Summary: MAPS-sponsored researcher Rachel Yehuda, Ph.D., of Icahn School of Medicine at Mount Sinai joins PBS’ Healthy Minds with Dr. Jeffrey Borenstein of the Brain & Behavior Research Foundation …
Summary: MAPS Public Benefit Corporation (MAPS PBC) CEO Amy Emerson is featured on the cover of the May 2022 issue of Life Science Leader! In the interview, Emerson explains how the public benefit model …
Summary: Bluntness Media highlights the contributions of eleven women in the psychedelic sphere, including Natalie_Lyla Ginsberg, M.S.W., and Bia Labate, Ph.D., of MAPS. Originally appearing here (Archived)
Summary: Bob Parsons, billionaire founder of GoDaddy, is an ex-Marine and still suffers from PTSD from his tour in Vietnam but credits LSD and MDMA with helping him “come home.” Now he’s on a mission …
Summary: Swedish media outlet SVT Nyheter explores the potential of MDMA-assisted therapy in treating PTSD, shares the personal experience of an individual who received such treatment, and considers the …
Summary: Michael Mithoefer, M.D., of MAPS Public Benefit Corporation (MAPS PBC) joins Newsy’s Clayton Sandell on The Why to discuss MAPS’ research of MDMA-assisted therapy for PTSD. Dr. Mithoefer …
Summary: “The aim of my role is to help as we shift from an organization that was focused on development of MDMA-assisted therapy to one focused on commercialization and licensure approval of that …
Summary: NEO.LIFE takes an interdisciplinary look at the role of psychiatrists as prescribers in the psychedelic field, featuring perspectives from psychiatrists, therapists, researchers, and policy experts. …
Summary: In the April 2022 issue of Harper’s BAZAAR, Andrea Stanley considers the benefits and risks of psychedelic use as it relates to parenthood. As MDMA-assisted therapy for PTSD and other psychedelic …
